Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | MAOA | P21397 | 13/20 | 0.44 |
| ▸ | MAOB | P27338 | 13/20 | 0.44 |
| ▸ | PRKCI | P41743 | 1/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.41 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.40 |
| ▸ | TYMS | P04818 | 1/20 | 0.39 |
| ▸ | CASP1 | P29466 | 1/20 | 0.39 |
| ▸ | CASP7 | P55210 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | GRM5 | P41594 | 1/20 | 0.38 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29618363 | 0.89 | CASP7 (0.50) | MEN1MAPK1KMT2ANPSR1MAOA | |
| SCHEMBL2300153 | 0.89 | CASP7 (0.50) | MEN1MAPK1KMT2ANPSR1MAOA | |
| SCHEMBL8615975 | 0.84 | MEN1 (0.55) | MEN1MAPK1KMT2ANPSR1MAOA | |
| SCHEMBL1027553 | 0.81 | MAPK1 (0.49) | MEN1MAPK1KMT2ANPSR1MAOA | |
| SCHEMBL434862 | 0.81 | TYMS (0.51) | MEN1MAPK1KMT2ANPSR1MAOA | |
| SCHEMBL23782883 | 0.78 | MEN1 (0.49) | MEN1MAPK1KMT2ANPSR1MAOA | |
| SCHEMBL16858594 | 0.78 | MAPK1 (0.49) | MEN1MAPK1KMT2ANPSR1MAOA | |
| SCHEMBL21155471 | 0.78 | MEN1 (0.49) | MEN1MAPK1KMT2ANPSR1MAOA | |
| SCHEMBL10750496 | 0.78 | MAPK1 (0.49) | MEN1MAPK1KMT2ANPSR1MAOA | |
| SCHEMBL15689674 | 0.78 | MAOA (0.49) | MEN1MAPK1KMT2ANPSR1MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11390733-B2 | Elastomeric formulations comprising branched EPDM polymers | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2022-07-19 | — | — | US | disclosed |
| US-10807997-B2 | Methods for making quinolinyldiamines | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2020-10-20 | — | — | US | disclosed |
| US-20200172717-A1 | Elastomeric Formulations Comprising Branched EPDM Polymers | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2020-06-04 | — | — | US | disclosed |
| US-20200071344-A1 | METHODS FOR MAKING QUINOLINYLDIAMINES | EXXONMOBIL CHEMICAL PATENTS INC. | 2020-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200071344-A1 | METHODS FOR MAKING QUINOLINYLDIAMINES | NNMT, PNMT, HNMT | MEN1 3890/4885MAPK1 4017/4885KMT2A 1795/4885 |
| US-10807997-B2 | Methods for making quinolinyldiamines | NNMT, PNMT, HNMT | MEN1 3890/4885MAPK1 4017/4885KMT2A 1795/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.